&w=3840&q=100)
Stratus Update: How XFG is likely to become the next dominant Covid variant
The most recent addition before XFG was NB.1.8.1 which the Who declared a variant under monitoring. Representational image/Pixabay
Given the number of times this has happened already, it should come as little surprise that we're now faced with yet another new subvariant of SARS-CoV-2, the virus responsible for Covid.
This new subvariant is known as XFG (nicknamed ' Stratus') and the World Health Organization (Who) designated it a 'variant under monitoring' in late June. XFG is a subvariant of Omicron, of which there are now more than 1,000.
A 'variant under monitoring' signifies a variant or subvariant which needs prioritised attention and monitoring due to characteristics that may pose an additional threat compared to other circulating variants.
STORY CONTINUES BELOW THIS AD
XFG was one of seven variants under monitoring as of June 25. The most recent addition before XFG was NB.1.8.1 (nicknamed 'Nimbus'), which the Who declared a variant under monitoring on May 23.
Both nimbus and stratus are types of clouds.
Nimbus is currently the dominant subvariant worldwide – but Stratus is edging closer. So, what do you need to know about Stratus or XFG?
A recombinant variant
XFG is a recombinant of LF.7 and LP.8.1.2, which means these two subvariants have shared genetic material to come up with the new subvariant. Recombinants are designated with an X at the start of their name.
While recombination and other spontaneous changes happen often with SARS-CoV-2, it becomes a problem when it creates a subvariant that is changed in such a way that its properties cause more problems for us.
Most commonly, this means the virus looks different enough that protection from past infection (and vaccination) doesn't work so well, called immune evasion. This basically means the population becomes more susceptible and can lead to an increase in cases, and even a whole new wave of Covid infections across the world.
XFG has four key mutations in the spike protein, a protein on the surface of SARS-CoV-2, which allows it to attach to our cells. Some are believed to enhance evasion by certain antibodies.
Early laboratory studies have suggested a nearly two-fold reduction in how well antibodies block the virus compared to LP.8.1.1.
STORY CONTINUES BELOW THIS AD
Where is XFG spreading?
The earliest XFG sample was collected on January 27.
As of June 22, there were 1,648 XFG sequences submitted to GISAID from 38 countries ( GISAID is the global database used to track the prevalence of different variants around the world). This represents 22.7 per cent of the globally available sequences at the time.
The advice for combating Covid remains unchanged, including vaccination as recommended and the early administration of antivirals for those who are eligible. Representational image/Pixabay
This was a significant rise from 7.4 per cent four weeks prior and only just below the proportion of NB.1.8.1 at 24.9 per cent. Given the now declining proportion of viral sequences of NB.1.8.1 overall, and the rapid rise of XFG, it would seem reasonable to expect XFG to become dominant very soon.
According to Australian data expert Mike Honey, the countries showing the highest rates of detection of XFG as of mid-June include India at more than 50 per cent, followed by Spain at 42 per cent, and the United Kingdom and United States, where the subvariant makes up more than 30 per cent of cases.
In Australia, as of June 29, NB.1.8.1 was the dominant subvariant, accounting for 48.6 per cent of sequences. In the most recent report from Australia's national genomic surveillance platform, there were 24 XFG sequences, with 12 collected in the last 28 days, meaning it currently comprises approximately 5 per cent of sequences.
STORY CONTINUES BELOW THIS AD
The big questions
When we talk about a new subvariant, people often ask questions, including if it's more severe or causes new or different symptoms compared to previous variants. But we're still learning about XFG and we can't answer these questions with certainty yet.
Some sources have reported XFG may be more likely to cause 'hoarseness' or a scratchy or raspy voice. But we need more information to know if this association is truly significant.
Notably, there's no evidence to suggest XFG causes more severe illness compared to other variants in circulation or that it is necessarily any more transmissible.
Will vaccines still work against XFG?
Relatively frequent changes to the virus mean we have continued to update the Covid vaccines. The most recent update, which targets the JN.1 subvariant, became available in Australia from late 2024. XFG is a descendant of the JN.1 subvariant.
Fortunately, based on the evidence available so far, currently approved Covid vaccines are expected to remain effective against XFG, particularly against symptomatic and severe disease.
Because of SARS-CoV-2's continued evolution, the effect of this on our immune response, as well as the fact that protection from Covid vaccines declines over time, Covid vaccines are offered regularly and recommended for those at the highest risk.
One of the major challenges we face at present in Australia is low Covid vaccine uptake. While rates have increased somewhat recently, they remain relatively low, with aged 75 years and over having received a vaccine in the past six months. Vaccination rates in younger age groups are significantly lower.
STORY CONTINUES BELOW THIS AD
Although the situation with XFG must continue to be monitored, at present the Who has assessed the global risk posed by this subvariant as low. The advice for combating Covid remains unchanged, including vaccination as recommended and the early administration of antivirals for those who are eligible.
Measures to reduce the risk of transmission, particularly wearing masks in crowded indoor settings and focusing on air quality and ventilation, are worth remembering to protect against Covid and other viral infections.
Paul Griffin, Professor, Infectious Diseases and Microbiology, The University of Queensland
This article is republished from The Conversation under a Creative Commons license. Read the original article.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Hans India
an hour ago
- Hans India
Life-saving surgeries, zero cost: Ayushman Bharat rescues poor in MP's Neemuch
Neemuch: A massive transformation is underway in the villages of Neemuch district, Madhya Pradesh, as the Ayushman Bharat Yojana, launched by Prime Minister Narendra Modi, continues to provide life-saving healthcare to the most economically vulnerable. Known as the Pradhan Mantri Jan Arogya Yojana (PM-JAY), this flagship initiative of the Central government has become a beacon of hope for families who once struggled with the burden of high medical expenses. Introduced in September 2018, the Ayushman Bharat scheme is the world's largest government-funded health insurance programme. It offers each eligible family an annual cashless healthcare cover of up to Rs 5 lakh, covering a wide range of treatments including diagnostics, secondary and tertiary care, surgeries, and even ICU stays at empanelled hospitals across India. Its goal -- to bring quality healthcare within reach of nearly 50 crore Indians. In Neemuch's villages -- especially Ummedpura and Medhki -- the scheme has changed lives. People who once had no means to afford expensive operations have now received advanced treatments completely free of cost. The stories of transformation are many, and each one speaks of survival, dignity, and renewed hope. Rajaram Bairagi, a small grocery shop owner from Medhki village, recalls the frightening days of 2020 when he suffered a heart attack during the COVID pandemic. With no financial resources to afford a costly surgery, his family was in despair. However, through the Ayushman Bharat card, he received treatment at a hospital in Ahmedabad, where his surgery—initially estimated to cost around Rs 1.5 lakh—was performed entirely free. 'This card gave me a new life. I will always be thankful to Modi ji for starting this scheme,' he told IANS. Dilip Kumar Piriya, a furniture shop owner from Ummedpura, shared a similar experience. He suffered from intense arm pain in 2019, and medical tests revealed four critical blockages in his heart. Doctors recommended an urgent bypass surgery that would cost upwards of Rs 4.5 lakh. With no means to bear the cost, Dilip turned to the Ayushman Bharat Yojana. Within a month, his surgery was conducted without any financial burden. 'It saved my life,' he said. 'There was no way I could have arranged such a huge amount. This scheme brought hope to my entire family,' he added. Farmers Labhachand Dhakad and Raghunath Singh Panwar also benefitted. Labhachand underwent a free angioplasty, while Raghunath received treatment for kidney stones that had caused him extreme pain. In both cases, families were spared from crippling medical debt. In Ummedpura, nearly 1,943 residents out of a total population of 2,508 now hold Ayushman cards. According to local officials, dozens of villagers have received free treatment for heart diseases and other serious conditions through this scheme. Artisans like Ashok Kumar Chhipa, who specialises in traditional Bandhej work, have also availed free angioplasty under the programme. For families who once faced the grim choice between incurring debt or forgoing treatment, Ayushman Bharat has become more than just a health insurance scheme -- it is a lifeline. In village after village, the stories echo a single truth: access to healthcare is no longer a privilege reserved for the few. Thanks to Ayushman Bharat, it is becoming a right for all. As India moves forward with digital health missions and universal care ambitions, the success stories from Neemuch stand as powerful proof that well-implemented policy can bring real change to even the remotest corners of the country.


Time of India
2 hours ago
- Time of India
'Misleading': Centre rejects Swiss firm's pollution rankings; cites limited government data usage by report
NEW DELHI: The central government on Thursday rejected the Swiss firm's IQAir report, that had ranked India the fifth most polluted country in the world, citing limited usage of government data in the survey. Tired of too many ads? go ad free now "However, it must be noted that only 38 per cent of the data sources used in the report are from government agencies. The remaining 62 per cent are from other agencies and include data generated using low-cost sensors," Union minister of state for environment Kirti Vardhan Singh said responding to a question by Congress MP Pramod Tiwari in the Rajya Sabha. "The data from a variety of monitors and sources, especially low-cost sensors, may have inaccuracies. Moreover, the report uses population-weighted averages based on data from urban monitoring stations, which may not represent the true national average," the minister said. "In view of these limitations and uncertainties in the data, the ranking of cities and countries may not portray the true picture and could be misleading," he added. In response to a query on whether air pollution is causing deaths and affecting public health nationwide, the minister said there is no conclusive data to establish a direct link between air pollution and mortality. "Air pollution is one of many contributing factors that can affect respiratory ailments and related diseases. Health is determined by several variables, including food habits, occupational exposure, socio-economic conditions, medical history, immunity, heredity and environmental factors," Singh said. According to IQAir's 2024 World Air Quality Report, India ranked as the fifth most polluted country in the world based on air quality data. The report named Byrnihat in Meghalaya as the most polluted metropolitan area globally, with an annual average PM2.5 concentration of 128.2 µg/m³, over 25 times higher than the WHO-recommended limit and more than three times the national standard.


News18
2 hours ago
- News18
Mizoram CM inaugurates trauma care facility at Aizawl Civil Hospital
Aizawl, Jul 24 (PTI) Mizoram Chief Minister Lalduhoma on Thursday inaugurated a trauma care facility at Aizawl Civil Hospital, marking a major step forward in strengthening emergency healthcare in the state. The facility was constructed at the cost of over Rs 5.7 crore, of which Rs 1.21 crore was funded by the Centre, according to officials. The facility includes a reception and triage area, treatment and observation rooms, imaging (X-ray/CT scan), a minor OT/resuscitation room, and rooms for medical staffers, they said. Speaking on the occasion, Lalduhoma said that the facility will serve as a vital centre for timely trauma response and critical care for the people. He stated that the government was also undertaking further expansion of the hospital, including the construction of new blocks A and B at an estimated cost of Rs 88.33 crore. Additional services such as cardiac care, kidney dialysis, and IVF will also be introduced to meet growing healthcare demands, he said. The chief minister said that Mizoram's doctors are highly skilled, and the government is committed to providing the facilities and infrastructure they need to deliver effective care, particularly for economically weaker sections. He also assured that the trauma care facility will continue to be upgraded based on practical needs and feedback from health professionals. Health Minister Lalrinpuii reaffirmed the department's dedication to advancing health services and thanked the chief minister for his continued support. Aizawl Civil Hospital Trauma Facility construction had been delayed due to a land dispute and the COVID-19 pandemic. It is one of seven trauma care facilities established across Mizoram. PTI CORR ACD view comments First Published: July 24, 2025, 20:00 IST Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.